Robert E. Campbell Pharmaceutical Seminar Series
Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues
Presentations from past Campbell Speakers
Market Access Strategy and Planning
March 2017
| Michael J. Lacey, MSc Senior Director Strategic Consulting Truven Health Analytics | View Slides |
Access, Affordability and Innovation: Focus on High Cost Medicines
February 2017
| Ashoke Bhattacharjya, Ph.D. Executive Director Johnson & Johnson | View Presentation |
Improving Success in Collaborative R&D by Selecting an Optimal Alliance Governance Structure and Partner Type
October 2016
Farok Contractor, Ph. D Jeongho Choi, Ph. D | View Presentation |
Re-thinking Translational Research: The Contribution of Basic and Clinical Research to Biomedical Innovation and Drug Discovery
September 2016
| Michelle Gittelman, Ph.D. Associate Professor Rutgers Business School | View Presentation |
Analytical Tools for Assessing Business Development Product and the Company Opportunity
February 2016
| Maged Shenouda, MBA INDEPENDENT DIRECTOR Relmada Therapeutics, Protea Biosciences and AzurRx Biopharma | View Presentation |
Biosimilars: Prospects for Competition and Savings
November 2015
| Joe Fuhr, Ph.D. ECONOMICS PROFESSOR Widener University | View Presentation |
Emerging Technologies in Healthcare: New Strategies for Social Media
October 2015
| Francoise Simon, Ph.D. CLINICAL PROFESSOR Columbia University | View Presentation |
Counterfeit, Black-Market and Off-Label Drug Use - Rot, Hot or Not
September 2015
| Robert Braunstein Clinical Professor Columbia University | View Presentation |
The Role of Capital in the Development and Life Cycle of a Biotech Company
March 2015
| Winston Kung Chief business officer Celgene Cellular Therapeutics | View Presentation |
Applying Supply Chain Mgmt. Concepts to Improve Healthcare Delivery
February 2015
| David Dobrzykowski DEPARTMENT OF SUPPLY CHAIN MANAGEMENT Rutgers Business School | View Presentation |
Transforming the Clinical Trial Enterprise - Patient-Centered Clinical Trials
Transforming Big Pharma - Assessing the Strategic Alternatives
September 2014
| John Ansell President John Ansell Consultancy | View Presentation |